Kaplan–Meier analysis showed that there was no significant difference in overall survival comparing all glioblastoma patients with relatively high or low IP10 expression (log-rank test, χ2 = 0.03, df = 1, p = 0.869) (see Figure 3D). This evidence concerns the gene CXCL10 and glioblastoma.